| Norman S Nielson, MD | |
|
799 S 200 W, Blanding, UT 84511-3909 | |
| (435) 678-3601 | |
| (435) 678-3610 |
| Full Name | Norman S Nielson |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 799 S 200 W, Blanding, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558364125 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 1670941205 (Utah) | Primary |
| 207Q00000X | Family Medicine | 1670941205 (Utah) | Primary |
| Entity Name | The Er Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508967688 PECOS PAC ID: 3971605817 Enrollment ID: O20070223000645 |
News Archive
Up to three hours after a person experiences the first symptom of a stroke is often referred to as the "golden window." That's the period of time doctors say is crucial for patients to get to a hospital to receive medical care in order to restore blood flow to the brain and minimize or reverse damage.
A new partnership which harnesses world-class expertise will ensure patients benefit sooner from new treatments, diagnostics and prevention strategies.
The novel SARS-CoV-2 coronavirus that emerged in the city of Wuhan, China, last year and has since caused a large scale COVID-19 epidemic and spread to more than 70 other countries is the product of natural evolution, according to findings published today in the journal Nature Medicine.
An immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and IIc melanoma, according to the results of an international, randomized phase III clinical trial led by UPMC Hillman Cancer Center.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Norman S Nielson, MD 799 S 200 W, Blanding, UT 84511-3909 Ph: (435) 678-3601 | Norman S Nielson, MD 799 S 200 W, Blanding, UT 84511-3909 Ph: (435) 678-3601 |
News Archive
Up to three hours after a person experiences the first symptom of a stroke is often referred to as the "golden window." That's the period of time doctors say is crucial for patients to get to a hospital to receive medical care in order to restore blood flow to the brain and minimize or reverse damage.
A new partnership which harnesses world-class expertise will ensure patients benefit sooner from new treatments, diagnostics and prevention strategies.
The novel SARS-CoV-2 coronavirus that emerged in the city of Wuhan, China, last year and has since caused a large scale COVID-19 epidemic and spread to more than 70 other countries is the product of natural evolution, according to findings published today in the journal Nature Medicine.
An immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and IIc melanoma, according to the results of an international, randomized phase III clinical trial led by UPMC Hillman Cancer Center.
› Verified 3 days ago
Anna M Day, FNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 799 So 200 W, Blanding, UT 84511 Phone: 435-678-3601 Fax: 435-678-3610 | |
Dr. Mahana S Fisher, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 804 N 400 W, Blanding, UT 84511 Phone: 435-678-2254 Fax: 435-678-2534 | |
Lloyd Val Jones, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 910 S 300 W, Blanding, UT 84511 Phone: 435-678-3601 Fax: 435-678-3610 |